Carcinoma in situ of the skin of the left lower limb, including the hip, is a non-invasive malignancy characterized by abnormal cell growth confined to the epidermis. It is primarily caused by prolonged sun exposure, genetic predisposition, or immunosuppression. Accurate coding with ICD-10 Code D04.72 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track incidence and treatment outcomes effectively.
ICD-10 Code D04.72 represents carcinoma in situ of the skin located on the left lower limb, including the hip. This code is used to document cases where malignant cells are present but have not invaded deeper tissues. It is crucial for clinical documentation and billing, particularly when distinguishing between invasive and non-invasive skin cancers.
Carcinoma in situ of the skin of the left lower limb, including the hip, arises from the uncontrolled growth of abnormal skin cells. This condition requires medical attention due to its potential progression to invasive cancer if left untreated. Early detection and intervention are critical.
ICD-10 Code D04.72 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate billing.
In SOAP notes, ICD-10 Code D04.72 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prompt treatment of carcinoma in situ is crucial to prevent progression to invasive cancer. Treatment options may include surgical excision or topical chemotherapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.72 is critical in medical billing, particularly in hospital, ER, or outpatient settings.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm. |
| 11100 | Biopsy of skin, excisional, including margins. |
| 17000 | Destruction of skin lesions; first lesion. |
Common Questions About Using ICD-10 Code D04.72 for Carcinoma in situ of skin of left lower limb, including hip
What are the treatment options for carcinoma in situ?
Treatment options for carcinoma in situ include surgical excision, topical chemotherapy, and cryotherapy. The choice of treatment depends on the lesion's size, location, and patient factors.
How is carcinoma in situ diagnosed?
Carcinoma in situ is diagnosed through a skin biopsy, where a sample of the affected skin is examined microscopically for abnormal cells.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a type of cancer, but it is non-invasive, meaning it has not spread beyond the epidermis.
What is the prognosis for carcinoma in situ?
The prognosis for carcinoma in situ is generally excellent, especially with early detection and appropriate treatment, which can prevent progression to invasive cancer.
Clinical Notes
SOAP notes
DAP notes
AI medical notes